国科恒泰：公司未开展细胞免疫治疗相关业务，也未有相关公告披露

Core Viewpoint - The company, Guoke Hengtai, clarified that it has not engaged in cell immunotherapy-related business and has not disclosed any related announcements, emphasizing its commitment to focus on its core business and enhance its core competitiveness for high-quality development and mutual value enhancement for the company and its shareholders [1] Group 1 - The company has not initiated any cell immunotherapy-related business [1] - There are no related announcements disclosed by the company [1] - The company aims to focus on its main business and improve its core competitiveness [1]